Subscribe to Newsletter
Subspecialties Imaging & Diagnostics, Business and Innovation

Imaging that Enlightens

sponsored by Heidelberg Engineering

Figure 1. Retinal layers in OCT (left part of the image) and High-Res OCT (right part of the image). The visualization of the retinal layers is improved in the High-Res OCT image, providing additional details. For example, the internal limiting membrane can be differentiated from the retinal nerve fiber layer more easily and the Henle fiber layer can better be demarcated from the outer nuclear layer. Furthermore, the outer retinal bands can be seen in great detail.

Disclaimer: The High-Res OCT is an investigational device not available for sale. For more information, contact [email protected].

The Heidelberg Engineering SPECTRALIS® is an internationally renowned OCT platform, which combines confocal Scanning Laser Ophthalmoscopy (cSLO) with OCT, OCT angiography, dye-based angiography, and MultiColor imaging. One of the latest innovations – the High-Res OCT – is an investigational device with a light-source capable of providing an axial resolution of up to 3 µm that could bring researchers new insights into the retinal structure and vasculature. This investigational device is based on the existing SPECTRALIS multimodal imaging platform, with one major difference; the High-Res OCT generates greater axial resolution and allows clinicians to see more detail.

Beyond structural information

The optical axial resolution of an OCT system depends on two light source properties: the bandwidth and the central wavelength. To achieve a greater optical axial resolution with a longer central wavelength (for example, 1060 nm), a larger bandwidth will be required when compared with a near-infrared (NIR) or visible spectrum. The High-Res OCT works with a central wavelength of 840 nm and an increased bandwidth, making it possible to improve the optical axial resolution in tissue from 7 to 3 µm.

Increasing the bandwidth of the light source instantly improves the optical axial resolution and, in turn, reproduces the finest details of the eye. SD-OCT is the only current technology capable of achieving a significantly higher axial resolution and presently, there are no swept-source light sources with higher bandwidth available to allow the development of an SS-OCT device with increased axial resolution.

Figure 2. OCTA image taken with the High-Res OCT. This OCT angiography (OCTA) image taken with the High-Res OCT excellently shows the locations of flow within the retinal layers and the choriocapillaris. It could be a great aid to correlate microvasculature with microstructures in the retina.

Optimizing OCT technology

Over the last 30 years, OCT has become a powerful diagnostic tool by enabling non-invasive visualization of the posterior and anterior segments of the eye. The first OCT devices employed time-domain OCT (TD-OCT), which were shortly followed by spectral-domain OCT (SD-OCT) and swept-source OCT (SS-OCT) devices, which provided significantly higher speed, higher resolution, and contrast. SD-OCT and SS-OCT are both technologies that operate in the frequency domain.

SS-OCT coupled with a longer wavelength delivers the advantage of deeper optical depth penetration, while SD-OCT, used with a shorter wavelength, can provide higher contrast within the retina and superior optical axial resolution. This combination is particularly suited for visualization of the inner and outer retina to Bruch’s membrane, resulting in stunning images of great clarity and contrast.

To learn more about this topic, take a look at the paper “State-of-the-art commercial Spectral-Domain and SweptSource OCT technologies and their clinical applications in ophthalmology” at www.spectralis.info.

The improved axial resolution of the High-Res OCT of 3 µm results in clearer and more detailed images resolving even minuscule vessels in the retinal layers and the choriocapillaris. The High-Res OCT with its broader OCT light spectrum has the potential to provide clinicians with new enlightening insights.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Case Studies
Business & Profession Glaucoma
TrabEx Pro: The Next Level in MIGS

| Contributed by MST

The Missing Piece of the Dry Eye Puzzle

| Contributed by Quidel

Uncovering Ocular Comorbidity

| Contributed by Quidel

Related Product Profiles
Uncover the Unique DNA of SPECTRALIS®

| Contributed by Heidelberg Engineering

Subspecialties Cornea / Ocular Surface
Tear Osmolarity – Empowering. Established. Essential.

| Contributed by TearLab

Subspecialties Retina
ForeseeHome® – remote monitoring to help detect wet AMD earlier and improve outcomes

| Contributed by Notal Vision

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: